Chiome Bioscience Inc. Logo

Chiome Bioscience Inc.

Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.

4583 | T

Overview

Corporate Details

ISIN(s):
JP3205350006
LEI:
Country:
Japan
Address:
渋谷区本町三丁目12番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Chiome Bioscience Inc. is a clinical-stage biotechnology company established in 2005, specializing in the research and development of therapeutic antibodies. The company focuses on addressing unmet medical needs by creating innovative antibody-based drugs. It utilizes a portfolio of proprietary technologies, most notably its ADLib® system, to accelerate the discovery and selection of optimal antibody candidates for its drug pipeline. Chiome Bioscience is engaged in advancing its own therapeutic programs and providing antibody development support and services to partners in the pharmaceutical industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-12 09:05
Report Publication Announcement
確認書
Japanese 8.3 KB
2025-08-12 09:04
Interim Report
半期報告書-第22期(2025/01/01-2025/12/31)
Japanese 188.7 KB
2025-03-28 08:09
Governance Information
内部統制報告書-第21期(2024/01/01-2024/12/31)
Japanese 22.8 KB
2025-03-28 08:07
Registration Form
確認書
Japanese 8.3 KB
2025-03-28 08:05
Annual Report
有価証券報告書-第21期(2024/01/01-2024/12/31)
Japanese 1.6 MB
2025-03-28 08:03
Post-Annual General Meeting Information
臨時報告書
Japanese 30.6 KB
2025-02-19 08:04
Audit Report / Information
臨時報告書
Japanese 19.7 KB
2024-11-15 07:48
Registration Form
確認書
Japanese 8.4 KB
2024-11-15 07:45
Annual Report
訂正有価証券報告書-第20期(2023/01/01-2023/12/31)
Japanese 767.5 KB
2024-08-13 09:10
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-08-13 09:08
Interim Report
半期報告書-第21期(2024/01/01-2024/12/31)
Japanese 226.8 KB
2024-07-05 08:02
Registration Form
有価証券届出書(組込方式)
Japanese 264.6 KB
2024-05-14 09:12
Quarterly Report
四半期報告書-第21期第1四半期(2024/01/01-2024/03/31)
Japanese 185.2 KB
2024-05-14 09:12
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-03-26 08:50
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB

Automate Your Workflow. Get a real-time feed of all Chiome Bioscience Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chiome Bioscience Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chiome Bioscience Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

TechnoPro Holdings, Inc. Logo
Technology staffing and services group providing engineers and solutions for R&D and development.
Japan
6028
TechTarget, Inc. Logo
Provides purchase intent-driven marketing and sales services for B2B tech vendors.
United States of America
TTGT
Tenaya Therapeutics, Inc. Logo
Developing gene therapy, cellular regeneration & precision medicine for heart disease.
United States of America
TNYA
Terns Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing small-molecule drugs for oncology & metabolic diseases.
United States of America
TERN
A holding company active in property rentals and marine seismic & defense R&D.
Virgin Islands (British)
THAL
Holding company for real estate development, building management, and community-integrated hotels.
Japan
3271
The Lifestyle Group Logo
Developed luxury/well-being ventures & provided multimedia systems for franchise network growth.
Italy
TLSG
Theranexus Logo
A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.
France
ALTHX
THE WHY HOW DO COMPANY, Inc. Logo
A corporate regeneration platform for business turnarounds, M&A, and succession solutions.
Japan
3823
Tiziana Life Sciences Ltd Logo
Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.
United States of America
TLSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.